With the ever-increasing complexity of Phase I trials, Worldwide has you covered.
It is our mission to deliver better data, faster, without compromising quality, allowing your asset to accelerate to the next step. Operating since 2005, our clinical pharmacology unit is a 200-bed, highly flexible, fit-for-purpose unit. Our patient database capabilities span a broad range of specialized populations, including CNS, cardiovascular, and metabolic patient populations.
We offer a range of early phase contract research organization (CRO) services executed by professionals fully dedicated to your early development program. These services include:
Take a tour of Worldwide’s Clinical Pharmacology Unit:
Chief Scientific Officer, Early Phase Development, Sherilyn Adcock, RPh, PhD provides key insight to our clinical development teams and to sponsors as they navigate the complexities of early phase drug development. Based in Austin, Texas, she has played a leading role in the Worldwide’s growth since joining as Director of Clinical Research in 2001.
Lona Sheeran brings more than two decades of operational and financial excellence to her role as Senior Vice President, Clinical Operations Early Phase, at Worldwide Clinical Trials. Lona applies her deep analytical skills honed through years of risk and benefit oversight and experience with Lean Six Sigma techniques to ensure the company’s clinical pharmacology unit in Austin, Texas, continues to exceed customer expectations.
Mike Mencer, Executive Vice President and General Manager of the Early Phase Business Unit for Worldwide Clinical Trials, has more than 25 years of experience in drug development and research. His career encompasses both the science and the business of therapeutic investigational research and includes oversight of multi-site, multi-country investigational projects. Providing strategic leadership to Worldwide’s Early Phase team, he ensures sponsors start their novel therapies off on the right foot.
Andrew has managed laboratories for more than 30 years across an array of service providers. His management experience includes:
Andrew has scientific and laboratory experience in such therapeutic areas as oncology, immunology, hematology, and cardiovascular disease, with early research work focusing on leukemia biology, stem cells, chemotherapy, antisense, immunophenotyping, and apoptosis.
Marie T. Simerly, PMP, Senior Director, Project Management Early Phase at Worldwide Clinical Trials brings nearly 25 years of Early Phase Project Management experience. She encourages and actively guides the development of each Project Manager to his/her full potential. Her expertise and vision for strategic partnerships with our Sponsors give Worldwide an advantage in developing strong client relationships.